[Myocardial revascularization in acute coronary syndrome without ST-segment elevation].
Currently, an invasive strategy is highly recommended in the management of patients with an acute coronary syndrome without persistent ST segment elevation. This early invasive strategy using angiocoronarography allows the identification of the culprit lesion which can be very frequently treated by stent implantation. The use of glycoprotein IIb/IIIa receptor inhibition is recommended especially for high risk patients, not only for the early benefit during medical treatment but also for the additional protection during percutaneous coronary intervention. Patients with left main or three-vessel disease, especially those with associated left ventricular dysfunction or diabetes, are usually managed with coronary artery bypass graft.
Service des maladies du coeur et des vaisseaux CHU Côte de Nacre 14033 Caen. hamon-m@chu-caen.fr
Martial
M
Hamon
D000208:Acute Disease; D015906:Angioplasty, Balloon, Coronary; D001145:Arrhythmias, Cardiac; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000473:pathology / Q000601:surgery*; D048909:Diabetes Complications; D004569:Electroencephalography; D006801:Humans; D009204:Myocardial Revascularization / Q000379:methods*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D018570:Risk Assessment; D013577:Syndrome; D018487:Ventricular Dysfunction, Left
D019039:Platelet Glycoprotein GPIIb-IIIa Complex